Probiotics and obesity

Annals of Nutrition and Metabolism

Volumn 57, Issue SUPPL. 1, 2010, Pages 20-23

  Blaut, M ^a   Bischoff, S C ^b  

^a GERMAN INSTITUTE OF HUMAN NUTRITION   (Germany)

^b UNIVERSITY OF HOHENHEIM   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCAGON LIKE PEPTIDE 2; GLUCOSE; OCCLUDIN; PROBIOTIC AGENT; PROTEIN ZO1;

BIFIDOBACTERIUM; BIFIDOBACTERIUM LONGUM INFANTIS; GLUCOSE TOLERANCE; HUMAN; INTESTINE EPITHELIUM; INTESTINE FLORA; INTESTINE MUCOSA PERMEABILITY; LIPID DIET; METABOLIC SYNDROME X; NONHUMAN; OBESITY; PRIORITY JOURNAL; SHORT SURVEY;

ANIMALS; BIFIDOBACTERIUM; BODY WEIGHT; FOOD HABITS; HUMANS; INTESTINES; MICE; OBESITY; PROBIOTICS;

EID: 77956499760     PISSN: 02506807     EISSN: None     Source Type: Journal    
DOI: 10.1159/000309079     Document Type: Short Survey

References (15)

1. Turnbaugh PJ, Ley RE, Mahowald MA, Magrini V, Mardis ER, Gordon JI: An obesity-associated gut microbiome with increased capacity for energy harvest. Nature 2006; 444: 1027-1031.
2. Ley RE, Turnbaugh PJ, Klein S, Gordon JI: Microbial ecology: human gut microbes associated with obesity. Nature 2006; 444: 1022-1023.
3. Ley RE, Backhed F, Turnbaugh P, Lozupone CA, Knight RD, Gordon JI: Obesity alters gut microbial ecology. Proc Natl Acad Sci USA 2005; 102:11070-11075.
4. Duncan SH, Lobley GE, Holtrop G, Ince J, Johnstone AM, Louis P, Flint HJ: Human co-lonic microbiota associated with diet, obesity and weight loss. Int J Obes (Lond) 2008; 32: 1720-1724.
5. Schwiertz A, Taras D, Schafer K, Beijer S, Bos NA, Donus C, Hardt PD: Microbiota and SCFA in lean and overweight healthy subjects. Obesity (Silver Spring) 2010; 18:190-195.
6. Turnbaugh PJ, Ridaura VK, Faith JJ, Rey FE, Knight R, Gordon JI: The ef fect of diet on the human gut microbiome: a metagenomic analysis in humanized gnotobiotic mice. Sci Transl Med DOI: 10.1126/scitranslmed. 3000322.
7. Backhed F, Ding H, Wang T, Hooper LV, Koh GY, Nagy A, Semenkovich CF, Gordon JI: The gut microbiota as an environmental factor that regulates fat storage. Proc Natl Acad Sci USA 2004; 101:15718-15723.
8. Cani PD, Amar J, Iglesias MA, Poggi M, Knauf C, Bastelica D, Neyrinck AM, Fava F, Tuohy KM, Chabo C, Waget A, Delmee E, Cousin B, Sulpice T, Chamontin B, Ferrieres J, Tanti JF, Gibson GR, Casteilla L, Delzenne NM, Alessi MC, Burcelin R: Metabolic endo-toxemia initiates obesity and insulin resistance. Diabetes 2007; 56: 1761-17 7 2.
9. Cani PD, Bibiloni R, Knauf C, Waget A, Neyrinck AM, Delzenne NM, Burcelin R: Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice. Diabetes 2008; 57: 1470-1481.
10. Bergheim I, Weber S, Vos M, Krämer S, Voly-nets V, Kaserouni S, McClain CJ, Bischoff SC: Antibiotics protect against fructose-induced hepatic lipid accumulation in mice: role of endotoxin. J Hepatol 2008; 48:983-992.
11. Spruss A, Kanuri G, Wagnerberger S, Haub S, Bischoff SC, Bergheim I: Toll-like receptor 4 is involved in the development of fructose-induced hepatic steatosis in mice. Hepatol-ogy 2009; 50:1094-1104.
12. Cani PD, Neyrinck AM, Fava F, Knauf C, Burcelin RG, Tuohy KM, Gibson GR, Del-zenne NM: Selective increases of bifidobac-teria in gut microflora improve high-fat-diet-induced diabetes in mice through a mechanism associated with endotoxaemia. Diabetologia 2007; 50:2374-2383.
13. Cani PD, Possemiers S, Van De Wiele T, Guiot Y, Everard A, Rottier O, Geurts L, Naslain D, Neyrinck A, Lambert DM, Muc-cioli GG, Delzenne NM: Changes in gut mi-crobiota control inf lammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeability. Gut 2009; 58: 10 91-110 3.
14. Cani PD, Delzenne NM: The role of the gut microbiota in energy metabolism and metabolic disease. Curr Pharm Des 2009; 15: 1546-1558.
15. Ewaschuk JB, Diaz H, Meddings L, Died er ichs B, D my t r a sh A, B ack er J, L ooije r-va n Langen M, Madsen KL: Secreted bioactive factors from Bifidobacterium infantis enhance epithelial cell barrier function. Am J Physiol Gastrointest Liver Physiol 2008; 2 95:G10 2 5-G103 4.